World's Best Scientists 2026 revealed!

D-Index & Metrics

Biology and Biochemistry

D-Index
65
Citations
52069
World Ranking
8911
National Ranking
245

Overview

Massimo Dominici is affiliated with the University of Modena and Reggio Emilia in Italy. Their research spans multiple topics within medicine and molecular biology, with a particular focus on oncology and regenerative medicine.

The scientist has contributed significantly to the study of mesenchymal stem cells and their therapeutic applications. Their recent publications cover a range of topics, including the development of potency tests for mesenchymal stromal cell-derived small extracellular vesicles (2021, Cytotherapy), and considerations for extracellular vesicles from mesenchymal stromal cells in the context of COVID-19 therapies (2020, Cytotherapy).

Other notable works include investigations into tumor growth dynamics emphasizing cancer stem cells in drug resistance and recurrence (2022, Cancers), genetic engineering to improve mesenchymal stem/stromal cells' therapeutic efficacy (2020, Frontiers in Cell and Developmental Biology), and the impact of interruptions in mammographic screening on breast cancer stage and treatment during the COVID era (2021, ESMO Open).

Massimo Dominici's coauthors frequently include:

  • Federico Piacentini
  • Giulia Grisendi
  • Andrea Spallanzani
  • Valentina Masciale
  • Angela Toss

Key publication venues for their work are:

  • Annals of Oncology
  • Journal of Clinical Oncology
  • International Journal of Molecular Sciences
  • Cytotherapy
  • Cancers

The main fields of study for Massimo Dominici's research include:

  • Medicine
  • Biochemistry, Genetics and Molecular Biology

Within these fields, their subfields of study focus on:

  • Oncology
  • Pulmonary and Respiratory Medicine
  • Molecular Biology
  • Cancer Research
  • Genetics

The scientist's main research topics cover:

  • Mesenchymal stem cell research
  • Cancer Genomics and Diagnostics
  • Cholangiocarcinoma and Gallbladder Cancer Studies
  • Cancer Cells and Metastasis
  • CAR-T cell therapy research
  • Cancer Immunotherapy and Biomarkers
  • Advanced Breast Cancer Therapies

Best Publications

  • Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement

    M. Dominici;K. Le Blanc;I. Mueller;I. Slaper-Cortenbach

  • Minimal information for studies of extracellular vesicles 2018 (MISEV2018) : a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines

    Clotilde Théry;Kenneth W. Witwer;Elena Aikawa;Maria Jose Alcaraz

  • Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

    E.M. Horwitz;K. Le Blanc;M. Dominici;I. Mueller

  • Stromal cells from the adipose tissue-derived stromal vascular fraction and culture expanded adipose tissue-derived stromal/stem cells: A joint statement of the International Federation for Adipose Therapeutics and Science (IFATS) and the International Society for Cellular Therapy (ISCT)

    Philippe Bourin;Bruce A. Bunnell;Louis Casteilla;Massimo Dominici

  • International Society for Cellular Therapy perspective on immune functional assays for mesenchymal stromal cells as potency release criterion for advanced phase clinical trials

    Jacques Galipeau;Mauro Krampera;John Barrett;Francesco Dazzi

  • Defining mesenchymal stromal cell (MSC)-derived small extracellular vesicles for therapeutic applications

    Kenneth W. Witwer;Bas W.M. Van Balkom;Stefania Bruno;Andre Choo

  • Human bone marrow mesenchymal stromal cells express the neural ganglioside GD2: a novel surface marker for the identification of MSCs

    Caridad Martinez;Ted J. Hofmann;Roberta Marino;Roberta Marino;Massimo Dominici

  • Human multipotent mesenchymal stromal cells use galectin-1 to inhibit immune effector cells.

    Friederike Gieseke;Judith Böhringer;Rita Bussolari;Massimo Dominici

  • Adipose-Derived Mesenchymal Stem Cells as Stable Source of Tumor Necrosis Factor–Related Apoptosis-Inducing Ligand Delivery for Cancer Therapy

    Giulia Grisendi;Rita Bussolari;Luigi Cafarelli;Istvan Petak

  • Animal serum-free culture conditions for isolation and expansion of multipotent mesenchymal stromal cells from human BM.

    Ingo Müller;S. Kordowich;C. Holzwarth;C. Spano

  • A Novel 3D In Vitro Platform for Pre-Clinical Investigations in Drug Testing, Gene Therapy, and Immuno-oncology

    Olivia Candini;Giulia Grisendi;Elisabetta Manuela Foppiani;Matteo Brogli

  • Challenges in Clinical Development of Mesenchymal Stromal/Stem Cells: Concise Review

    Ilenia Mastrolia;Elisabetta Manuela Foppiani;Alba Murgia;Olivia Candini

  • Restoration and reversible expansion of the osteoblastic hematopoietic stem cell niche after marrow radioablation.

    Massimo Dominici;Valeria Rasini;Rita Bussolari;Xiaohua Chen

  • Discordance in receptor status between primary and recurrent breast cancer has a prognostic impact: a single-Institution analysis

    Maria Vittoria Dieci;Elena Barbieri;Federico Piacentini;G Ficarra

  • Application of multipotent mesenchymal stromal cells in pediatric patients following allogeneic stem cell transplantation.

    Ingo Müller;Sandra Kordowich;Christina Holzwarth;Gesa Isensee

  • Rare Breast Cancer Subtypes: Histological, Molecular, and Clinical Peculiarities

    Maria Vittoria Dieci;Enrico Orvieto;Massimo Dominici;PierFranco Conte

  • Hematopoietic cells and osteoblasts are derived from a common marrow progenitor after bone marrow transplantation

    Massimo Dominici;Colin Pritchard;John E. Garlits;Ted J. Hofmann

  • How do mesenchymal stromal cells exert their therapeutic benefit

    E. M. Horwitz;Massimo Dominici

  • Development and functional characterization of human bone marrow mesenchymal cells immortalized by enforced expression of telomerase

    Keichiro Mihara;Chihaya Imai;Elaine Coustan-Smith;Jeffrey S. Dome;Jeffrey S. Dome

  • POSITION PAPER Clarification of the nomenclature for MSC: The International Society for Cellular Therapy position statement

    EM Horwitz;K Le Blanc;M Dominici;I Mueller

Frequent Co-Authors

Pierfranco Conte
Pierfranco Conte University of Padua
Daniel J. Weiss
Daniel J. Weiss University of Vermont
Nicola Baldini
Nicola Baldini University of Bologna
Hubert Schrezenmeier
Hubert Schrezenmeier University of Ulm
Donald G. Phinney
Donald G. Phinney Scripps Research Institute
Sai Kiang Lim
Sai Kiang Lim Agency for Science, Technology and Research
Bernd Giebel
Bernd Giebel University of Duisburg-Essen
Robert Deans
Robert Deans Osiris Therapeutics (United States)
Kenneth W. Witwer
Kenneth W. Witwer Johns Hopkins University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Best Scientists Citing Massimo Dominici

Trending Scientists